← Back to graph

Biomarker

stool calprotectin 24h urine

Selected indexed studies

Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA. (PLoS One, 2019) [PMID:30730969]
Risk profile of promoters and inhibitors of kidney stone formation in paediatric inflammatory bowel disease. (Pediatr Nephrol, 2025) [PMID:40560272]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA. (2019) pubmed
Risk profile of promoters and inhibitors of kidney stone formation in paediatric inflammatory bowel disease. (2025) pubmed

Local graph